Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old

Randomized multicenter phase II trial of timed-sequential therapy with flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus “7+3” for adults with newly diagnosed acute myeloid leukemia (AML).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7002 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7002-7002

Author(s):

Joshua F. Zeidner ◽

Matthew C. Foster ◽

Amanda Blackford ◽

Mark Robert Litzow ◽

Lawrence Morris ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Sequential Therapy ◽

Newly Diagnosed ◽

Multicenter Phase ◽

A phase II trial of VP 16–213 in adults with refractory acute myeloid leukemia

American Journal of Clinical Oncology ◽

10.1097/00000421-198410000-00015 ◽

1984 ◽

Vol 7 (5) ◽

pp. 471-474 ◽

Cited By ~ 32

Author(s):

John M Bennett ◽

Gary H. Lymann ◽

Peter A Cassileth ◽

John H. Glick ◽

Martin M. Oken

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia

Leukemia Research ◽

10.1016/j.leukres.2017.09.005 ◽

2017 ◽

Vol 61 ◽

pp. 108-116 ◽

Cited By ~ 16

Author(s):

Jonathan A. Webster ◽

Raoul Tibes ◽

Larry Morris ◽

Amanda L. Blackford ◽

Mark Litzow ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Cytosine Arabinoside ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Randomized Phase Ii ◽

Chk1 Inhibitor ◽

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia

Leukemia Research ◽

10.1016/s0145-2126(00)00043-6 ◽

2000 ◽

Vol 24 (10) ◽

pp. 871-875 ◽

Cited By ~ 20

Author(s):

Michael S Gordon ◽

Molly L Young ◽

Martin S Tallman ◽

Larry D Cripe ◽

John M Bennett ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

Blood Cancer Discovery ◽

10.1158/2643-3230.bcd-21-0070 ◽

2021 ◽

Cited By ~ 1

Author(s):

Joshua F. Zeidner ◽

Benjamin G. Vincent ◽

Anastasia Ivanova ◽

Dominic Moore ◽

Karen P. McKinnon ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

High Dose ◽

High Dose Cytarabine ◽

Pooled Clinical Safety Analysis of CPX-351 Versus Conventional Chemotherapy in Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.07.084 ◽

2019 ◽

Vol 19 ◽

pp. S214-S215

Author(s):

Jorge E. Cortes ◽

Robert J. Ryan ◽

Michael Chiarella

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Safety Analysis ◽

Newly Diagnosed ◽

Conventional Chemotherapy ◽

Clinical Safety ◽

A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia

European Journal Of Haematology ◽

10.1111/ejh.13544 ◽

2020 ◽

Author(s):

Jonathan Canaani ◽

Ivetta Danylesko ◽

Noga Shemtov ◽

Maya Zlotnick ◽

Kira Lozinsky ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Randomized phase 1 study of sequential (“primed”) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1728754 ◽

2020 ◽

Vol 61 (7) ◽

pp. 1728-1731

Author(s):

Raffaele Palmieri ◽

Sarah A. Buckley ◽

Megan Othus ◽

Anna B. Halpern ◽

Mary-Elizabeth M. Percival ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase 1 ◽

High Grade ◽

Newly Diagnosed ◽

Phase 1 Study ◽

Myeloid Neoplasm ◽

Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality

Leukemia ◽

10.1038/s41375-020-0916-8 ◽

2020 ◽

Vol 34 (11) ◽

pp. 2914-2924

Author(s):

Ghayas C. Issa ◽

Hagop M. Kantarjian ◽

Lianchun Xiao ◽

Jing Ning ◽

Yesid Alvarado ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

PCN331 HUMANISTIC BURDEN OF NEWLY DIAGNOSED VERSUS RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

Value in Health ◽

10.1016/j.jval.2019.09.526 ◽

2019 ◽

Vol 22 ◽

pp. S500

Author(s):

S. Panjabi ◽

A. Bychenkova ◽

C. McCloskey ◽

S. Nair ◽

K. Price ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Humanistic Burden ◽